SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

---
SK bioscience Initiates Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate
Vote:
0 0
Previous Ascenda and Galileo Financial Technologies Collaborate to Elevate Card Loyalty Programs
Next CARsgen Therapeutics Introduced Zhuhai SB Xinchuang to Accelerate Allogeneic CAR-T Cell Products Development in Mainland China

Related News

SK bioscience Receives Approval for Global Clinical Trials of mRNA Japanese Encephalitis Vaccine Candidate

SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs

SK bioscience Appoints New Executives to Accelerate New Growth Strategies

GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate

RVAC Medicines Secures HSA Approval to Initiate Phase 1B Clinical Trial in Singapore

RNAimmune Receives FDA Clearance of Investigational New Drug Application for Phase 1 Trial of RV-1730 COVID-19 Booster Vaccine

menu
menu